UPDATE: Fate Therapeutics (FATE) PT Raised to $42 at BTIG After Earnings Reiterated Top Pick
Tweet Send to a Friend
(Updated - March 3, 2020 7:11 AM EST)
BTIG analyst Amanda Murphy raised the price target on Fate Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BTIG analyst Amanda Murphy raised the price target on Fate Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
